Cargando…

PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation

SIMPLE SUMMARY: Five-year survival rates from patients with locally advanced cervical cancer (LACC) are between 40% and 60%. These patients are usually treated with chemoradiation or radiotherapy in combination with hyperthermia (thermoradiation). The aim of our study was to enhance chemoradiation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	IJff, Marloes, van Bochove, Gregor G. W., Whitton, Denise, Winiarczyk, Roy, Honhoff, Celina, Rodermond, Hans, Crezee, Johannes, Stalpers, Lukas J. A., Franken, Nicolaas A. P., Oei, Arlene L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123631/ https://www.ncbi.nlm.nih.gov/pubmed/33926008 http://dx.doi.org/10.3390/cancers13092092

Ejemplares similares

Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
por: IJff, Marloes, et al.
Publicado: (2018)

The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review
por: IJff, Marloes, et al.
Publicado: (2022)

The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Crezee, Hans, et al.
Publicado: (2019)

Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Crezee, Johannes, et al.
Publicado: (2020)

Sensitizing thermochemotherapy with a PARP1-inhibitor
por: Oei, Arlene L, et al.
Publicado: (2016)

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
por: Oei, Arlene L., et al.
Publicado: (2017)

Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines
por: Mei, Xionge, et al.
Publicado: (2020)

Decay of γ-H2AX foci correlates with potentially lethal damage repair and P53 status in human colorectal carcinoma cells
por: Van Oorschot, Bregje, et al.
Publicado: (2013)

Hyperthermia-Based Anti-Cancer Treatments
por: Crezee, Johannes, et al.
Publicado: (2021)

Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2022)

Entropic and Near-Field Improvements of Thermoradiative Cells
por: Hsu, Wei-Chun, et al.
Publicado: (2016)

A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
por: van Leeuwen, Caspar M., et al.
Publicado: (2017)

Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2023)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
por: Helderman, Roxan F.C.P.A., et al.
Publicado: (2020)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
por: Löke, Daan R., et al.
Publicado: (2020)

Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
por: Oei, Arlene L., et al.
Publicado: (2015)

A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors
por: Nuijens, Anna C., et al.
Publicado: (2022)

Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
por: Elming, Pernille B., et al.
Publicado: (2019)

Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer
por: Oei, Arlene L., et al.
Publicado: (2019)

Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments
por: Scutigliani, Enzo M., et al.
Publicado: (2022)

Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer
por: Crezee, J., et al.
Publicado: (2016)

HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings
por: Agnass, Pierre, et al.
Publicado: (2020)

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
por: Löke, Daan R., et al.
Publicado: (2021)

Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2019)

The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
por: van Leeuwen, C. M., et al.
Publicado: (2018)

Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom
por: Löke, Daan R., et al.
Publicado: (2023)

The Composition of Small Extracellular Vesicles (sEVs) in the Blood Plasma of Colorectal Cancer Patients Reflects the Presence of Metabolic Syndrome and Correlates with Angiogenesis and the Effectiveness of Thermoradiation Therapy
por: Yunusova, Natalia V., et al.
Publicado: (2023)

Thermoradiationally Modified Polytetrafluoroethylene as a Basis for Membrane Fabrication: Resistance to Hydrogen Penetration, the Effect of Ion Treatment on the Chemical Structure and Surface Morphology, Evaluation of the Track Radius
por: Moskvitin, Lev Vladimirovich, et al.
Publicado: (2023)

Local irradiation of patient-derived tumors in immunodeficient mice
por: van der Zalm, Amber P., et al.
Publicado: (2023)

Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
por: Helderman, Roxan F. C. P. A., et al.
Publicado: (2021)

Oxidative stress in cervical cancer and its response to chemoradiation
por: Shah, Saiqa, et al.
Publicado: (2019)

Reducing prolonged chemoradiation treatment times for cervical cancer
por: Vitzthum, Lucas, et al.
Publicado: (2019)

Influence of chemoradiation on the immune microenvironment of cervical cancer patients
por: Herter, J. M., et al.
Publicado: (2022)

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?
por: Furuse, Junji
Publicado: (2019)

Cervical necrosis after chemoradiation for cervical cancer: case series and literature review
por: Fawaz, Ziad Simon, et al.
Publicado: (2013)

HPV transcript expression affects cervical cancer response to chemoradiation
por: Ruiz, Fiona J., et al.
Publicado: (2021)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation
por: Kanjanapan, Yada, et al.
Publicado: (2017)

Treatment of acute radiation cystitis: reply by the authors
por: Hazewinkel, Menke, et al.
Publicado: (2011)

Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment
por: van Oorschot, Bregje, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gvmiu78rvt6q9oqc6etn3pum8r